Phaos Technology Holdings (Cayman) (POAS) Debt to Equity (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Debt to Equity of -$0.07 for Q2 2025, down 134.7% year-on-year from $0.2 in Q2 2024, and down 134.7% on a QoQ basis from $0.2 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Debt to Equity data on file, last reported at -$0.07 in Q2 2025.
- For the quarter ending Q2 2025, Debt to Equity fell 134.7% year-over-year to -$0.07; the trailing twelve-month figure through Apr 2025 stood at -$0.07 (down 134.7% YoY), and the FY2025 full-year result was -$0.07, down 134.7% from the prior year.
- Debt to Equity for Q2 2025 stood at -$0.07, down from $0.2 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.2 in Q2 2024 and bottomed at -$0.07 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -0.07 |
| Apr 30, 2024 | 0.20 |